IHS Chemical Week

World News and Views :: Top of the News

Solvay Shareholder Denies Approach from Sanofi-Aventis

2:36 AM MDT | April 2, 2009 | Natasha Alperowicz

Solvac (Brussels), the family owned holding vehicle, which controls 30.07% in Solvay, has denied press reports that it has been approached about the potential sale of Solvay's pharmaceuticals business. "Solvac denies any contact with third parties about the sale of its participation in Solvay, in part or in total," the company said today. A report in the Financial Times stated that Sanofi-Aventis has made a direct approach to Solvac but that Solvac rejected the offer, which valued the whole company at €7.2 billion ($9.6...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa